BR9202156A - Acilamino-2-tiazois e processo para sua preparacao,compostos e composicao farmaceutica - Google Patents

Acilamino-2-tiazois e processo para sua preparacao,compostos e composicao farmaceutica

Info

Publication number: BR9202156A
Authority: BR; Brazil
Prior art keywords: group; alkyl; optionally substituted; image; optionally
Prior art date: 1991-06-05

Application number

BR929202156A

Other languages

English (en)

Inventor

Robert Boigegrain

Roger Brodin

Danielle Gully

Jean-Charles Molimard

Dominique Olliero

Original Assignee

Sanofi Elf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-05

Filing date

1992-06-05

Publication date

1993-02-02

1992-06-05 Application filed by Sanofi Elf filed Critical Sanofi Elf

1993-02-02 Publication of BR9202156A publication Critical patent/BR9202156A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BR929202156A 1991-06-05 1992-06-05 Acilamino-2-tiazois e processo para sua preparacao,compostos e composicao farmaceutica BR9202156A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9106814A FR2677356B1 (fr)	1991-06-05	1991-06-05	Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.

Publications (1)

Publication Number	Publication Date
BR9202156A true BR9202156A (pt)	1993-02-02

Family

ID=9413505

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BR929202156A BR9202156A (pt)	1991-06-05	1992-06-05	Acilamino-2-tiazois e processo para sua preparacao,compostos e composicao farmaceutica
BR1100786-9A BR1100786A (pt)	1991-06-05	1997-05-12	Derivados heterocìclicos de 2-acilamino 5-tiázois substituìdos, sua preparação e composições farmacêuticas contendo os mesmos

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BR1100786-9A BR1100786A (pt)	1991-06-05	1997-05-12	Derivados heterocìclicos de 2-acilamino 5-tiázois substituìdos, sua preparação e composições farmacêuticas contendo os mesmos

Country Status (24)

Country	Link
US (2)	US5314889A (pt)
EP (1)	EP0518731B1 (pt)
JP (1)	JP3199451B2 (pt)
KR (1)	KR100222309B1 (pt)
AT (1)	ATE170186T1 (pt)
AU (1)	AU650754B2 (pt)
BR (2)	BR9202156A (pt)
CA (1)	CA2070526A1 (pt)
CZ (1)	CZ289003B6 (pt)
DE (1)	DE69226729T2 (pt)
ES (1)	ES2121575T3 (pt)
FI (1)	FI922589A (pt)
FR (1)	FR2677356B1 (pt)
HK (1)	HK1012397A1 (pt)
HU (1)	HU221312B1 (pt)
IE (1)	IE921814A1 (pt)
IL (1)	IL102004A (pt)
MX (1)	MX9202662A (pt)
NO (1)	NO300135B1 (pt)
NZ (1)	NZ243009A (pt)
RU (1)	RU2059637C1 (pt)
TW (1)	TW202448B (pt)
UA (1)	UA26899C2 (pt)
ZA (1)	ZA923981B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4303676A1 (de) *	1993-02-09	1994-08-11	Bayer Ag	1-Aryltriazolin(thi)one
FR2701708B1 (fr) *	1993-02-19	1995-05-19	Sanofi Elf	Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) *	1993-04-16	1995-07-21	Sanofi Elf	5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
WO1995032963A1 (fr) *	1994-06-01	1995-12-07	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de thienylazole et compose de thienotriazolodiazepine
MX9604483A (es) *	1994-09-08	1998-02-28	Jean-Francois Rossignol	Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US6187536B1 (en)	1997-02-18	2001-02-13	Thomas Jefferson University	Methods of identifying and detecting pancreatic cancer
FR2768737B1 (fr) *	1997-09-19	2000-05-19	Sanofi Sa	Derives de carboxamidothiazoles, leur preparation, les compositions pharmaceutiques en contenant
CO4970713A1 (es)	1997-09-19	2000-11-07	Sanofi Synthelabo	Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
GB0028383D0 (en) *	2000-11-21	2001-01-03	Novartis Ag	Organic compounds
US7169931B2 (en) *	2001-01-26	2007-01-30	Shionogi & Co., Ltd.	Cyclic compounds exhibiting thrombopoietin receptor agonism
WO2002062775A1 (fr) *	2001-02-02	2002-08-15	Yamanouchi Pharmaceutical Co., Ltd.	Dérivé de 2-acylaminothiazole ou son sel
ES2610611T3 (es) *	2002-01-18	2017-04-28	Astellas Pharma Inc.	Derivado de 2-acilaminotiazol o sal del mismo
US20030225054A1 (en) *	2002-06-03	2003-12-04	Jingwu Duan	Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
FR2854158B1 (fr) *	2003-04-25	2006-11-17	Sanofi Synthelabo	Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
CN1835948B (zh) *	2003-07-17	2010-05-26	安斯泰来制药有限公司	2-酰基氨基噻唑衍生物或其盐
ES2629414T3 (es) *	2003-12-26	2017-08-09	Kyowa Hakko Kirin Co., Ltd.	Derivados de tiazol
JP2008514547A (ja)	2004-05-23	2008-05-08	ハウシー・ファーマシューティカルズ・インコーポレーテッド	セラミューテイン・モジュレーター
FR2872813B1 (fr) *	2004-07-09	2007-01-19	Sanofi Synthelabo	Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
RU2007109073A (ru) *	2004-08-13	2008-09-20	Дженентек, Инк. (Us)	Ингибиторы для атф-зависимого фермента на основе тиазола
FR2876692B1 (fr) *	2004-10-19	2007-02-23	Sanofi Aventis Sa	Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
JP4774995B2 (ja) *	2005-01-12	2011-09-21	アステラス製薬株式会社	アシルアミノチアゾール誘導体を有効成分とする医薬組成物
JP2009513563A (ja) *	2005-06-03	2009-04-02	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
US20100280023A1 (en) *	2005-06-23	2010-11-04	Kyowa Hakko Kogyo Co., Ltd.	Thiazole derivatives
PT1921077T (pt)	2005-08-02	2017-10-26	Kyowa Hakko Kirin Co Ltd	Agente para tratar e/ou prevenir distúrbio do sono
JP2009514941A (ja) *	2005-11-08	2009-04-09	アステラス製薬株式会社	血小板減少症を治療する化合物および方法
FR2895989B1 (fr) *	2006-01-06	2010-04-30	Sanofi Aventis	Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
EP1983980A4 (en) *	2006-01-25	2010-05-05	Synta Pharmaceuticals Corp	THIAZOL AND THIADIAZOL COMPOUNDS FOR USES IN RELATION TO INFLAMMATION AND IMMUNITY
CN101096363B (zh) *	2006-06-27	2011-05-11	中国人民解放军军事医学科学院毒物药物研究所	2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
JP2010500361A (ja) *	2006-08-08	2010-01-07	アカークス，インコーポレーテッド	ヒトの血小板レベルを増加させるための組成物および方法
WO2009089305A1 (en) *	2008-01-07	2009-07-16	Synta Pharmaceuticals Corp.	Compounds for inflammation and immune-related uses
RU2506267C2 (ru) *	2008-03-31	2014-02-10	Дженентек, Инк.	Бензопирановые и бензоксепиновые ингибиторы рi3k и их применение
EP2464352A1 (en) *	2009-08-14	2012-06-20	Eisai Inc.	Use of e5501 for stimulating platelet production
RU2015104301A (ru) *	2009-09-28	2015-11-10	Ф.Хоффманн-Ля Рош Аг	Бензоксепиновые ингибиторы р13 и способы применения
TWI423980B (zh)	2009-09-28	2014-01-21	Hoffmann La Roche	苯并氧氮呯ｐｉ３ｋ抑制劑化合物及使用方法
CA2793311C (en) *	2010-03-17	2019-01-15	Taivex Therapeutics Inc.	Modulators of hec1 activity and methods therefor
EP2688891B1 (en)	2011-03-21	2017-11-15	F. Hoffmann-La Roche AG	Benzoxazepin compounds selective for pi3k p110 delta and methods of use
BR112014019209A2 (pt)	2012-02-17	2017-07-04	Hoffmann La Roche	compostos tricíclicos e métodos de uso para os mesmos
JP2022500499A (ja)	2018-09-07	2022-01-04	ピクセラピューティクス，インコーポレイテッド	Ｅｉｆ４ｅ阻害剤およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3210368A (en) *	1964-09-29	1965-10-05	Ciba Geigy Corp	Certain 2-amino-4-aryl-5-n, n-disubstituted amino-lower alkyl-thiazole compounds
EP0208510B1 (en) *	1985-07-09	1991-09-11	Pfizer Inc.	1-substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents
DE3705934A1 (de) *	1987-02-25	1988-09-08	Nattermann A & Cie	Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4971978A (en) *	1987-09-21	1990-11-20	Nadzan Alex M	Derivatives of D-glutamic acid and D-aspartic acid
US4992437A (en) *	1987-12-22	1991-02-12	Yoshitomi Pharmaceutical Industries, Ltd.	Thienodiazepine compounds and their pharmaceutical use
IE68593B1 (en) *	1989-12-06	1996-06-26	Sanofi Sa	Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them

1991
- 1991-06-05 FR FR9106814A patent/FR2677356B1/fr not_active Expired - Fee Related
1992
- 1992-05-26 IL IL102004A patent/IL102004A/xx not_active IP Right Cessation
- 1992-05-28 AU AU17279/92A patent/AU650754B2/en not_active Ceased
- 1992-05-29 US US07/889,910 patent/US5314889A/en not_active Expired - Fee Related
- 1992-06-01 TW TW081104270A patent/TW202448B/zh active
- 1992-06-01 ZA ZA923981A patent/ZA923981B/xx unknown
- 1992-06-03 DE DE69226729T patent/DE69226729T2/de not_active Expired - Fee Related
- 1992-06-03 ES ES92401518T patent/ES2121575T3/es not_active Expired - Lifetime
- 1992-06-03 AT AT92401518T patent/ATE170186T1/de not_active IP Right Cessation
- 1992-06-03 EP EP92401518A patent/EP0518731B1/fr not_active Expired - Lifetime
- 1992-06-03 NZ NZ243009A patent/NZ243009A/en unknown
- 1992-06-04 JP JP14415092A patent/JP3199451B2/ja not_active Expired - Fee Related
- 1992-06-04 HU HU9201870A patent/HU221312B1/hu not_active IP Right Cessation
- 1992-06-04 CZ CS19921693A patent/CZ289003B6/cs not_active IP Right Cessation
- 1992-06-04 CA CA002070526A patent/CA2070526A1/en not_active Abandoned
- 1992-06-04 MX MX9202662A patent/MX9202662A/es not_active IP Right Cessation
- 1992-06-04 RU SU5011874/04A patent/RU2059637C1/ru not_active IP Right Cessation
- 1992-06-04 FI FI922589A patent/FI922589A/fi not_active Application Discontinuation
- 1992-06-04 NO NO922215A patent/NO300135B1/no not_active IP Right Cessation
- 1992-06-05 KR KR1019920009859A patent/KR100222309B1/ko not_active IP Right Cessation
- 1992-06-05 BR BR929202156A patent/BR9202156A/pt not_active Application Discontinuation
- 1992-07-01 IE IE181492A patent/IE921814A1/en not_active IP Right Cessation
1993
- 1993-06-15 UA UA93002939A patent/UA26899C2/uk unknown
1994
- 1994-03-03 US US08/205,408 patent/US5380736A/en not_active Expired - Fee Related
1997
- 1997-05-12 BR BR1100786-9A patent/BR1100786A/pt active IP Right Grant
1998
- 1998-12-16 HK HK98113673A patent/HK1012397A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ289003B6 (cs)	2001-10-17
AU1727992A (en)	1992-12-10
BR1100786A (pt)	2000-03-14
HK1012397A1 (en)	1999-07-30
JP3199451B2 (ja)	2001-08-20
HUT75870A (en)	1997-05-28
DE69226729T2 (de)	1999-05-06
EP0518731B1 (fr)	1998-08-26
HU9201870D0 (en)	1992-08-28
RU2059637C1 (ru)	1996-05-10
CS169392A3 (en)	1992-12-16
FR2677356B1 (fr)	1995-03-17
JPH05155871A (ja)	1993-06-22
HU221312B1 (en)	2002-09-28
US5314889A (en)	1994-05-24
FR2677356A1 (fr)	1992-12-11
ATE170186T1 (de)	1998-09-15
ZA923981B (en)	1993-12-01
ES2121575T3 (es)	1998-12-01
FI922589A0 (fi)	1992-06-04
KR930000492A (ko)	1993-01-15
KR100222309B1 (ko)	1999-10-01
NO300135B1 (no)	1997-04-14
IE921814A1 (en)	1992-12-16
CA2070526A1 (en)	1992-12-06
IL102004A0 (en)	1992-12-30
FI922589A (fi)	1992-12-06
AU650754B2 (en)	1994-06-30
NZ243009A (en)	1995-05-26
IL102004A (en)	1997-04-15
TW202448B (pt)	1993-03-21
DE69226729D1 (de)	1998-10-01
EP0518731A1 (fr)	1992-12-16
US5380736A (en)	1995-01-10
MX9202662A (es)	1992-12-31
NO922215D0 (no)	1992-06-04
UA26899C2 (uk)	1999-12-29
NO922215L (no)	1992-12-07

Publication	Publication Date	Title
BR9202156A (pt)	1993-02-02	Acilamino-2-tiazois e processo para sua preparacao,compostos e composicao farmaceutica
SE8406585L (sv)	1985-06-24	Bensoesyraderivat
PT95202A (pt)	1991-05-22	Processo para a preparacao de n-substituidas-4-pirimidinaminas e de composicoes farmaceuticas que os contem
ES2100907T3 (es)	1997-07-01	Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
DE3879681D1 (de)	1993-04-29	3-aryluracile zur unkrautbekaempfung.
ATE19776T1 (de)	1986-05-15	Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
SE8802412L (sv)	1988-12-31	Tiokarbamidderivat
ATE132861T1 (de)	1996-01-15	Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
LV11689A (lv)	1997-02-20	4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols
ATE30725T1 (de)	1987-11-15	Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel.
GR74679B (pt)	1984-07-03
ES523890A0 (es)	1985-04-01	Un procedimiento para preparar derivados de penem.
ATE10844T1 (de)	1985-01-15	Chinolincarbonsaeurederivat, verfahren zu seiner herstellung und es enthaltende bakterizide mittel.
ATE40117T1 (de)	1989-02-15	O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
ATE61585T1 (de)	1991-03-15	N-carboxyalcoyl-2-oxo-3-diaryl-5-6 triazine als heilmittel.
FI834798A (fi)	1984-06-29	Foerfarande foer framstaellning av 1-(aminoalkoxifenyl)-1-fenyl-propanoler.
GR82414B (pt)	1984-12-13
MX9102514A (es)	1992-09-01	Novedosos derivados de aminoalquilcetona, su procenovedosos derivados de aminoalquilcetona, su procenovedosos derivados de amino alquil cetona, su procedimiento de preparacion y sus aplicaciones terapdimiento de preparacion y sus aplicaciones terapeudimiento de preparacion y sus aplicaciones terapeuticas. ticas. euticas.

Legal Events

Date	Code	Title	Description
1997-11-18	FA	Application withdrawn